Knowing the results of psychedelics on human brain networks is vital to unlocking their therapeutic mechanisms. In humans, throughout the about 6 hour period of action, psilocybin increases glutamate signalling and glucose metabolism19,twenty,21, broadly decreases the strength of electrophysi